Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Genetically engineered stem cells may be advantageous for gene therapy against various human cancers due to their inherent tumor-tropic properties. In this study, genetically engineered human neural stem cells (HB1.F3) expressing Escherichia coli cytosine deaminase (HB1.F3.CD) and human interferon-β (HB1.F3.CD.IFN-β) were employed against lymph node-derived metastatic colorectal adenocarcinoma. CD can convert a prodrug, 5-fluorocytosine (5-FC), to active 5-fluorouracil (5-FU), which inhibits tumor growth through the inhibition of DNA synthesis, while IFN-β also strongly inhibits tumor growth by inducing the apoptotic process. In RT-PCR analysis, we confirmed that HB1.F3.CD cells expressed the CD gene and HB1.F3.CD.IFN-β cells expressed both CD and IFN-β genes. In results of a modified trans-well migration assay, HB1.F3.CD and HB1.F3.CD.IFN-β cells selectively migrated toward SW-620, human lymph node-derived metastatic colorectal adenocarcinoma cells. The viability of SW-620 cells was significantly reduced when co-cultured with HB1.F3.CD or HB1.F3.CD.IFN-β cells in the presence of 5-FC. In addition, it was found that the tumor-tropic properties of these engineered hNSCs were attributed to chemoattractant molecules including s SDF-1, c-kit, uPAR, uPA and CCR2s secreted by SW-620 cells. In a xenograft mouse model, treatment with hNSC resulted in significantly inhibited growth of the tumor mass without virulent effects on the animals. The current results indicate that engineered hNSCs and a prodrug treatment inhibited the growth of SW-620 cells. Therefore, hNSC therapy may be a clinically effective tool for the treatment of lymph node metastatic colorectal cancer.

Citation

Geon-Tae Park, Seung U Kim, Kyung-Chul Choi. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β Against Lymph Node-derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models. Cancer research and treatment : official journal of Korean Cancer Association. 2016 May 3


PMID: 27188205

View Full Text